The Food and Drug Administration has accepted a new drug application for berdazimer gel 10.3% for the treatment of molluscum contagiosum, the manufacturer announced on March 7. If approved, berdazimer […]
For patients with high-risk non–muscle-invasive bladder cancer (NMIBC), the gold-standard systemic therapy for preventing disease recurrence and progression following transurethral resection is bacillus Calmette-Guérin (BCG). However, […]
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.